| ²é¿´: 393 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
GOVERN1688½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
Ó¢ÒëÖÐ1-лл
|
|
| It was also under development by licensee Threshold Pharmaceuticals (as TH-070) for the potential treatment of benign prostatic hyperplasia (BPH), but was discontinued in July 2006, when it failed to meet its endpoints in a phase II US trial and phase III Europe and Canada trial. |
» ²ÂÄãϲ»¶
281Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
»ªÄÏÀí¹¤0703»¯Ñ§£¬×Ü·Ö336Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ13È˻ظ´
295Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
²ÄÁÏÓ뻯¹¤×¨Ë¶306·ÖÕÒºÏÊʵ÷¼Á
ÒѾÓÐ3È˻ظ´
0703µ÷¼Á£¬Ò»Ö¾Ô¸Ìì½ò´óѧ319·Ö
ÒѾÓÐ11È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ21È˻ظ´
²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
319Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
xux730
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 86
- Ó¦Öú: 1719 (½²Ê¦)
- ½ð±Ò: 10740.4
- É¢½ð: 50
- ºì»¨: 43
- Ìû×Ó: 2947
- ÔÚÏß: 336.5Сʱ
- ³æºÅ: 1374299
- ×¢²á: 2011-08-20
- רҵ: ϸ°ûÖÜÆÚÓëµ÷¿Ø
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
GOVERN1688: ½ð±Ò+10, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ллÄú 2013-09-18 08:45:50
GOVERN1688: ½ð±Ò+10, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ллÄú 2013-09-18 08:45:50
| ÕâÖÖÒ©Ò²ÓɳÖÅÆÈË£¨»òרÀûÓµÓÐÈË£©THRESHOLD£¨ãÐÖµ£©ÖÆÒ©ÉÌ£¨TH-070£©¿ª·¢Æä×÷ΪÁ¼ÐÔǰÁÐÏÙÔöÉúÖ¢£¨BPH£©µÄDZÔÚÖÎÁÆÊֶΣ¬µ«ÔÚ2006Äê7Ô±»ÖÕÖ¹£¬ÕâÊÇÓÉÓÚËüÔÚÃÀ¹úµÄIIÆÚºÍÅ·ÖÞ¡¢¼ÓÄôóµÄIIIÆÚÁÙ´²ÊÔÑéÖÐûÓдﵽԤÆÚ¡£ |
2Â¥2013-09-17 19:11:17














»Ø¸´´ËÂ¥